Aura Biosciences, Inc. - Common Stock (AURA)

Historical Holders from Q4 2021 to Q3 2025

Symbol
AURA on Nasdaq
CUSIP
05153U107
Type / Class
Equity / Common Stock
Shares outstanding
61.8M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
51.6M
Holdings value
$319M
% of all portfolios
0%
Grand Portfolio weight change
+0%
Number of holders
105
Number of buys
48
Number of sells
-36
Average Value change %
0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Aura Biosciences, Inc. - Common Stock (AURA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Matrix Capital Management Company, LP 11.17% $38.2M 6.92M Matrix Capital Management Company LP May 16, 2025
SUVRETTA CAPITAL MANAGEMENT, LLC 7.6% +25% $30.6M $10.7M 4.7M +53.8% Suvretta Capital Management, LLC Jun 30, 2025
BlackRock, Inc. 5.4% +10% $20.6M $1.84M 3.34M +9.81% BlackRock, Inc. Sep 30, 2025
Long Focus Capital Management, LLC 6.6% +32% $18.3M $4.48M 3.32M +32.4% LONG FOCUS CAPITAL MANAGEMENT, LLC Mar 31, 2025
Frazier Life Sciences Public Fund, L.P. 5% -49% $20.2M -$20.8M 3.11M -50.7% Frazier Life Sciences Public Fund, L.P. Jun 30, 2025

Institutional Holders of Aura Biosciences, Inc. - Common Stock (AURA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 51.6M $319M +$6.25M $6.18 105
2025 Q2 50.6M $317M +$67.4M $6.26 102
2025 Q1 39.3M $230M -$11.9M $5.86 91
2024 Q4 39.4M $324M +$17.1M $8.22 93
2024 Q3 36.9M $329M -$25.8M $8.91 82
2024 Q2 39.6M $300M +$3.31M $7.56 74
2024 Q1 39.1M $307M +$16.2M $7.85 77
2023 Q4 11.8K $104K -$203K $8.86 1
2023 Q3 26.3M $236M -$5.57M $8.97 62
2023 Q2 27.1M $334M +$25M $12.35 59
2023 Q1 25.1M $233M +$11.2M $9.28 57
2022 Q4 23.8M $250M +$78.2M $10.50 48
2022 Q3 16.3M $296M +$9.71M $18.12 43
2022 Q2 15.7M $223M +$28.9M $14.17 41
2022 Q1 13.7M $299M +$9.08M $22.00 33
2021 Q4 13.1M $220M +$220M $16.98 32